Equities

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year AstraZeneca PLC grew net income 23.86% from 2.83bn to 3.50bn despite declining revenues.
Gross margin82.63%
Net profit margin14.81%
Operating margin21.31%
Return on assets5.56%
Return on equity20.99%
Return on investment7.52%
More ▼

Cash flow in USDView more

In 2016, cash reserves at AstraZeneca PLC fell by 1.13bn. However, the company earned 4.15bn from its operations for a Cash Flow Margin of 18.02%. In addition the company used 3.97bn on investing activities and also paid 1.32bn in financing cash flows.
Cash flow per share3.55
Price/Cash flow per share13.21
Book value per share9.14
Tangible book value per share-15.01
More ▼

Balance sheet in USDView more

AstraZeneca PLC has a Debt to Total Capital ratio of 50.21%, a lower figure than the previous year's 76.46%.
Current ratio0.8693
Quick ratio0.7163
Total debt/total equity1.13
Total debt/total capital0.5021
More ▼

Growth rates in USD

Year on year, growth in dividends per share fell -3.56% while earnings per share excluding extraordinary items rose 23.76%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked below the industry average relative to its peers.
Div yield(5 year avg)0.08%
Div growth rate (5 year)-0.72%
Payout ratio (TTM)101.77%
EPS growth(5 years)-17.55
EPS (TTM) vs
TTM 1 year ago
23.78
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.